CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)

Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.

Never miss a new study

Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear

Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1

New hope for tough leukemia: experimental drug MS-553 enters human testing

Disease control Not yet recruiting

This early-phase trial tests an experimental drug called MS-553 in 12 adults whose chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) has returned or stopped responding to other treatments. The main goal is to check the drug's safety and side effects. MS-553 w…

Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)

Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control

Last updated May 06, 2026 16:13 UTC

CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)

Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear

New hope for tough leukemia: experimental drug MS-553 enters human testing